flulaval
Vaccineexperimental
Influenza vaccines, colloquially known as flu shots or the flu jab, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. Vaccination against influenza began in the 1930s, with large-scale availability in the United States beginning in 1945. — Wikipedia
Clinical trial activity
10 trials · 18 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
4
Phase 3
2
Phase 4
2
Earliest trial started Aug 5, 2008 (NCT00727428)
Timeline
Indications
Approved for
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaInfluenza vaccine ↗
Also known as
- flulaval
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05170399 | Phase 4 | Sep 14, 2022 | National Heart, Lung, and Blood Institute (NHLBI) |
| NCT03598439 | Phase 4 | Jul 30, 2018 | Centers for Disease Control and Prevention (CDC), Marshfield Clinic Research Foundation |
| NCT02831751 | Phase 2 | Apr 1, 2016 | Broward Research Group, Centre de Recherche St-Louis, Quebec, Canada, INC Research, McGill University, Medicago, Meridien Research, MRA Clinical Research, Omnispec Clinical Research Inc, Mirabel, Canada, Paradigm Research, Regional Clinical Research, Topstone Research, Toronto, Canada, University of Montreal |
| NCT02242643 | Phase 3 | Oct 1, 2014 | GlaxoSmithKline |
| NCT01974895 | Phase 2 | Oct 1, 2013 | GlaxoSmithKline |
| NCT01196975 | Phase 3 | Oct 1, 2010 | GlaxoSmithKline |
| NCT01059617 | Phase 1 | Feb 9, 2010 | GlaxoSmithKline |
| NCT00858611 | Phase 1 | Mar 3, 2009 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00902278 | N/A | Oct 1, 2008 | University of Massachusetts |
| NCT00727428 | Phase 1 | Aug 5, 2008 | GlaxoSmithKline |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (18)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 5 | 5 | 3 | 2008 |
| Broward Research Group | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Centers for Disease Control and Prevention (CDC) | Government | 1 | 0 | 1 | 2018 |
| Centre de Recherche St-Louis, Quebec, Canada | Academic/Hospital | 1 | 0 | 1 | 2016 |
| INC Research | For profit | 1 | 0 | 1 | 2016 |
| Marshfield Clinic Research Foundation | Academic/Hospital | 1 | 1 | 1 | 2018 |
| McGill University | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Medicago | For profit | 1 | 1 | 1 | 2016 |
| Meridien Research | For profit | 1 | 0 | 1 | 2016 |
| MRA Clinical Research | Academic/Hospital | 1 | 0 | 1 | 2016 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 1 | 1 | 2022 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2009 |
| Omnispec Clinical Research Inc, Mirabel, Canada | For profit | 1 | 0 | 1 | 2016 |
| Paradigm Research | For profit | 1 | 0 | 1 | 2016 |
| Regional Clinical Research | For profit | 1 | 0 | 1 | 2016 |
| Topstone Research, Toronto, Canada | For profit | 1 | 0 | 1 | 2016 |
| University of Massachusetts | Academic/Hospital | 1 | 1 | 1 | 2008 |
| University of Montreal | Academic/Hospital | 1 | 0 | 1 | 2016 |
18 organizations
Page 1 / 1